Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Liminal Biosciences Inc (NQ: LMNL ) N/A UNCHANGED Last Price Updated: 3:59 PM EDT, Sep 25, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Liminal Biosciences Inc < Previous 1 2 3 Next > Why Lucid Group Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session July 12, 2023 Gainers Healthcare Triangle, Inc. (NASDAQ: HCTI) shares climbed 171.2% to $8.84 as the company launched initiative to prevent ransomware attacks in the $35 billion healthcare data market. Via Benzinga Liminal BioSciences Stock Gains0% Today - Here's Why? July 12, 2023 Liminal BioSciences Inc (NASDAQ: LMNL) shares are trading higher after Structured Alpha, a fund managed by Thomvest Asset Management, agreed to Via Benzinga Why SeaChange International Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket April 06, 2023 Gainers Via Benzinga Liminal BioSciences Pulls Plug On Its Lead Development Program July 22, 2022 Via Benzinga Ocugen To Buy Liminal's Dormant Vaccine Manufacturing Plant In Canada January 27, 2022 Ocugen Inc (NASDAQ: OCGN) has Via Benzinga The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline August 18, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 17) AbbVie Inc. (NYSE: ABBV)... Via Benzinga Exposures Product Safety Dow Rises 80 Points; MarketAxess Holdings Shares Slide April 05, 2023 U.S. stocks traded mixed toward the end of trading, with the Dow Jones gaining around 80 points on Wednesday. The Dow traded up 0.24% to 33,482.53 while the NASDAQ fell 1.21% to 11,979.98. The S&P 500,... Via Benzinga Why Kura Sushi Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session April 05, 2023 Gainers Nuburu, Inc. (NYSE: BURU) shares jumped 104% to $5.55 after the company announced it has been selected by the U.S. Department of Defense for a position on the multiple award Indefinite... Via Benzinga Nasdaq Tumbles 150 Points; Liminal BioSciences Shares Spike Higher April 05, 2023 U.S. stocks traded mostly lower midway through trading, with the Nasdaq Composite dropping around 150 points on Wednesday. The Dow traded up 0.07% to 33,425.80 while the NASDAQ fell 1.27% to 11,972.78.... Via Benzinga The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business August 17, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 16) Bio-Rad Laboratories, Inc... Via Benzinga Why Is Freight Technologies (FRGT) Stock Up 25% Today? April 05, 2023 Freight Technologies (FRGT) stock is heading higher on Wednesday after announcing a record number of new clients in March. Via InvestorPlace Why Is Liminal Biosciences (LMNL) Stock Up 77% Today? April 05, 2023 Liminal Biosciences (LMNL) stock is taking off on Wednesday as investors react to the company getting an unsolicited transaction proposal. Via InvestorPlace Markets Mixed; US Trade Deficit Widens In February April 05, 2023 U.S. stocks traded mixed this morning, with the Nasdaq Composite dropping more than 50 points on Wednesday. Following the market opening Wednesday, the Dow traded up 0.13% to 33,446.10 while the NASDAQ... Via Benzinga Stocks That Hit 52-Week Lows On Tuesday January 03, 2023 On Tuesday, 31 stocks hit new 52-week lows. Via Benzinga Earnings Scheduled For March 15, 2023 March 15, 2023 Companies Reporting Before The Bell • Sportradar Gr (NASDAQ:SRAD) is estimated to report quarterly earnings at $0.04 per share on revenue of $208.09 million. Via Benzinga Stocks That Hit 52-Week Lows On Thursday December 29, 2022 On Thursday, 116 companies set new 52-week lows. Via Benzinga Daily Biotech Pulse: VistaGen's Anxiety Study Fails, Silverback To Merge With Firm Developing EpiPen Alternative, Setback For Liminal's Lead Asset July 22, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga Why Karuna Therapeutics Jumped Around 72%; Here Are 96 Biggest Movers From Yesterday August 09, 2022 Gainers Helbiz, Inc. (NASDAQ: HLBZ) jumped 114.6% to close at $1.61 on Monday after climbing over 27% on Friday. Via Benzinga This Technology Stock Surged 235%; Here Are 77 Biggest Movers From Friday July 25, 2022 Gainers Via Benzinga Liminal BioSciences Outlines Plans To Further Develop Its Lead Compound March 14, 2022 Liminal BioSciences Inc (NASDAQ: LMNL) has provided an update on plans for further developing its lead compound fezagepras. The announcement follows the... Via Benzinga Americans’ Appetite for Vaccine Options Bodes Well for Ocugen February 21, 2022 OCGN stock is definitely out of favor on Wall Street, but fresh poll data and an imminent R&D hub acquisition should spur some optimism. Via InvestorPlace Liminal BioSciences Pauses Development Of Fezagepras, Outlines R&D Priorities For 2022 January 20, 2022 Following the analysis of the preliminary pharmacokinetic data from the Phase I MAD trial, Liminal BioSciences Inc (NASDAQ: LMNL) said that it would not be... Via Benzinga The Daily Biotech Pulse: Coherus Soars On Lung Cancer Data, Illumina Closes On Grail Buy Without Regulatory Clearance, Adagene Strikes Collaboration With Merck August 19, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 18) AbbVie Inc. (NYSE: ABBV)... Via Benzinga The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs October 08, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 7) Alkermes plc (NASDAQ: ALKS)... Via Benzinga Exposures Product Safety The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results October 07, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 6) Enanta Pharmaceuticals, Inc... Via Benzinga The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal October 06, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 5) Bicycle Therapeutics plc (... Via Benzinga The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout October 05, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 4) Avadel Pharmaceuticals plc (... Via Benzinga The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data August 20, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 19) Alkermes plc (NASDAQ: ALKS... Via Benzinga Exposures COVID-19 Stocks That Hit 52-Week Lows On Monday August 16, 2021 On Monday morning, 207 companies hit new 52-week lows. Intriguing Points: The largest company in terms of market cap to set a new 52-week low was Koninklijke Philips (NYSE... Via Benzinga 24 Stocks Moving in Monday's Pre-Market Session August 16, 2021 Gainers Enlivex Therapeutics Ltd. (NASDAQ: ENLV) shares rose 26.6% to $12.87 in pre-market trading after the company disclosed that after reviewing its earlier-reported Phase II... Via Benzinga < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.